![]() |
Volumn 1, Issue 1, 2000, Pages 9-17
|
Acute myeloid leukemia in adults.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ACUTE DISEASE;
ADULT;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MULTIMODALITY CANCER THERAPY;
MYELOID LEUKEMIA;
PATHOLOGY;
PROGNOSIS;
REMISSION;
REVIEW;
RISK FACTOR;
SURVIVAL RATE;
ACUTE DISEASE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, MYELOID;
PROGNOSIS;
REMISSION INDUCTION;
RISK FACTORS;
SURVIVAL RATE;
|
EID: 0034174774
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-000-0011-3 Document Type: Review |
Times cited : (22)
|
References (25)
|